On this episode of Stock Movers:

- Novo Nordisk fell as Morgan Stanley downgraded its rating to underweight on weaker prescription momentum for the firm’s weight-loss drugs.

- GSK CEO Emma Walmsley is stepping down after almost nine years with chief commercial officer Luke Miels taking over on January 1st.

- Lufthansa gained after the airline outlined new financial goals, including plans to cut 4,000 administrative jobs by 2030.

On this episode of Stock Movers:
- Novo Nordisk fell as Morgan Stanley downgraded its rating to underweight on weaker prescription momentum for the firm&rsquo;s weight-loss drugs.
- GSK CEO Emma Walmsley is stepping down after almost nine years with chief commercial officer Luke Miels taking over on January 1st.
- Lufthansa gained after the airline outlined new financial goals, including plans to cut 4,000 administrative jobs by 2030.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Novo Nordisk Down, GSK Departure, Lufthansa Up

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b06d409f-6fef-4b8e-bc71-b367008d150e/transcript

Advertisement